Fenghai Ren
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 2
- TGF-β signaling in diseases 2
- RNA and protein synthesis mechanisms 1
- Signaling Pathways in Disease 1
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Co-authors
- Dawei Sun (3 shared papers)Shidong Xu (2 shared papers)Jianlong Bu (2 shared papers)Junfeng Wang (3 shared papers)Xuhai Zhao (1 shared paper)Yubo Yan (1 shared paper)Xianglong Kong (1 shared paper)Mengfeng Liu (1 shared paper)
- Journals
- Frontiers in Oncology (1 paper)Human & Experimental Toxicology (1 paper)Oncotarget (1 paper)PLoS ONE (1 paper)Frontiers in Genetics (1 paper)
- Partner nations
- China
In The Last Decade
Fenghai Ren
10 papers receiving 445 citations
Fenghai Ren's Hit Papers
Peers
Comparison fields: 5 of 49
- Cancer Research 270
- Molecular Biology 354
- Immunology 34
- Oncology 35
- Pulmonary and Respiratory Medicine 34
Countries citing papers authored by Fenghai Ren
This map shows the geographic impact of Fenghai Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenghai Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenghai Ren more than expected).
Fields of papers citing papers by Fenghai Ren
This network shows the impact of papers produced by Fenghai Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenghai Ren. The network helps show where Fenghai Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Fenghai Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma Hit paper breakdown → | 2020 | 307 |
| 2 | 2014 | 44 | |
| 3 | 2017 | 38 | |
| 4 | 2021 | 21 | |
| 5 | 2021 | 14 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 7 | |
| 8 | 2017 | 5 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 2 |
About Fenghai Ren
Fenghai Ren is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 448 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (4 papers), Genetic factors in colorectal cancer (2 papers), RNA modifications and cancer (2 papers), TGF-β signaling in diseases (2 papers), RNA and protein synthesis mechanisms (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Cancer Research (270 citations), Molecular Biology (354 citations), Immunology (34 citations), Oncology (35 citations) and Pulmonary and Respiratory Medicine (34 citations). Fenghai Ren has collaborated with scholars based in China. Frequent co-authors include Dawei Sun, Shidong Xu, Jianlong Bu, Junfeng Wang, Xuhai Zhao, Yubo Yan, Xianglong Kong, Mengfeng Liu, Yanbo Wang and Yanbo Wang. Their work appears in journals such as Frontiers in Oncology, Human & Experimental Toxicology, Oncotarget, PLoS ONE and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.